Search results
Results from the WOW.Com Content Network
Astonishingly, the stock's market cap isn't even $6 billion today, and it has a 4.6 price-to-sales ratio. For comparison, tech stock Palantir trades at a blistering 70 times sales.
Hims & Hers is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s decision to end compounded GLP-1s on the market.The tracker allows patients to self-identify, provide ...
In this video, Travis Hoium covers the day's news and why this isn't a big deal for investors. *Stock prices used were end-of-day prices of Oct. 3, 2024. The video was published on Oct. 3, 2024.
Discover the latest breaking news in the U.S. and around the world — politics, weather, ... USA TODAY Sports. NFL free agency 2025: Ranking top 25 free agents.
U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular weight-loss drug Wegovy to patients in certain professions for $99 a month.
Hims Inc. was established in 2017 by Jack Abraham, Andrew Dudum and Hilary Coles as a part of the Atomic Labs portfolio. [7] [1] In January 2019, Hims raised $100 million in a Series C funding round with a pre-money valuation of $1 billion. [8] [9] In the same month, Hims was launched in the United Kingdom with a catalogue limited by European ...
In Other News. Entertainment. Entertainment. USA TODAY. ... USA TODAY. Rare winter storm that smacked much of the South turns deadly; dig-out begins. Weather. USA TODAY.
Hims & Hers (NYSE: HIMS) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the stock. But the business is about much more than just one product, and ...